FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to use of an anti-leukinetic and antibacterial pharmaceutical composition as an antioxidant and inducer of human mononuclear cell apoptosis. Use of an anti-leukemia and antibacterial pharmaceutical composition containing metronidazole, silver hexamethylene tetramine nitrate, sodium thiosulphate and water, as an antioxidant and apoptosis inducer of human mononuclear cells taken in a certain ratio.
EFFECT: disclosed pharmaceutical composition has effective antioxidant activity and is an effective apoptosis inducer of human mononuclear cells.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIOXIDANT COMPOSITION (VERSIONS) | 2015 |
|
RU2593587C1 |
ANTI-LEUCOSIS AND ANTI-MICROBIAL COMPOSITION | 2006 |
|
RU2339376C2 |
METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING BOVINE VIRAL LEUKOSIS | 2016 |
|
RU2608130C1 |
ANTIOXIDANT COMPOSITION | 2010 |
|
RU2446799C2 |
AGENT POSSESSING APOPTOSIS-INDUCING ACTIVITY | 2018 |
|
RU2702656C1 |
APOPTOSIS-INDUCING AGENTS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2709498C1 |
ANTITUMOR AND ANTIBACTERIAL COMPOSITION | 1999 |
|
RU2181050C2 |
ANTITUMOR, ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION (ITS VARIANTS) | 2006 |
|
RU2319491C1 |
CYTOSTATIC AND ANTIVIRAL COMPOSITION | 1995 |
|
RU2094048C1 |
COMPOSITION WITH ANTIOXIDANT AND ANTIBACTERIAL ACTIVITY | 2013 |
|
RU2535140C1 |
Authors
Dates
2019-03-20—Published
2017-06-13—Filed